Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer.

Int J Mol Sci · 2016 · PMC5037797 · PMID 27618028

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

showed a trendp = 0.11not close (p > 0.1)

In this analysis, PHI also showed a trend towards shortened PFS in case of an early increase (HR: 2.0 (95% CI: 0.9–5.0); p = 0.11).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.